|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008059,
umls-concept:C0013216,
umls-concept:C0023449,
umls-concept:C0025677,
umls-concept:C0035020,
umls-concept:C0079172,
umls-concept:C0205527,
umls-concept:C0231449,
umls-concept:C0332293,
umls-concept:C0927232,
umls-concept:C1554078,
umls-concept:C1708528
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1995-12-4
|
|
pubmed:abstractText |
To assess the effect of treatment intensification and that of extended intrathecal methotrexate substitution for cranial irradiation in intermediate-risk acute lymphoblastic leukemia (ALL) children treated with a Berlin-Frankfurt-Münster (BFM)-based intensive chemotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
2497-502
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7595699-6-Mercaptopurine,
pubmed-meshheading:7595699-Adolescent,
pubmed-meshheading:7595699-Antimetabolites, Antineoplastic,
pubmed-meshheading:7595699-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7595699-Asparaginase,
pubmed-meshheading:7595699-Brain Neoplasms,
pubmed-meshheading:7595699-Child,
pubmed-meshheading:7595699-Child, Preschool,
pubmed-meshheading:7595699-Combined Modality Therapy,
pubmed-meshheading:7595699-Cranial Irradiation,
pubmed-meshheading:7595699-Cyclophosphamide,
pubmed-meshheading:7595699-Cytarabine,
pubmed-meshheading:7595699-Daunorubicin,
pubmed-meshheading:7595699-Female,
pubmed-meshheading:7595699-Humans,
pubmed-meshheading:7595699-Infant,
pubmed-meshheading:7595699-Injections, Spinal,
pubmed-meshheading:7595699-Male,
pubmed-meshheading:7595699-Methotrexate,
pubmed-meshheading:7595699-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:7595699-Prednisone,
pubmed-meshheading:7595699-Recurrence,
pubmed-meshheading:7595699-Regression Analysis,
pubmed-meshheading:7595699-Remission Induction,
pubmed-meshheading:7595699-Survival Analysis,
pubmed-meshheading:7595699-Vincristine
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
|
|
pubmed:affiliation |
Department of Pediatrics, University of Milano, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
